Technology | November 01, 2012

Terumo Launches Peripheral Access System

New system facilitates smooth, reliable and precise vascular access

November 1, 2012 — Terumo Interventional Systems announced the nationwide availability of its new Pinnacle Precision Access System. The vascular access system specifically designed for smooth, efficient and reliable peripheral vascular access. It offers the only available tapered introducer needle to minimize vessel trauma, dilate the tissue and gain more precise access in difficult cases, such as those impeded by scar tissue or calcification.

“Terumo’s Pinnacle Precision Access System is one of the most innovative advancements in technology that will help us achieve success in peripheral vascular intervention, specifically where critical limb ischemia (CLI) is present,” said Jihad Mustapha, M.D., FACC, FSCAI, director of endovascular laboratories and director of cardiovascular research at Metro Heart and Vascular, Metro Health Hospital, in Wyoming, Mich. “From the tapered needle to the TIF (total integrated fit) sheath, Terumo provides a seamless transition for vascular access femorally or peripherally.”

One of the system’s most significant advantages is the elimination of procedural steps compared to alternative products. Traditionally, once access is achieved, the site is gradually enlarged to the desired French size by exchanging to a larger wire and sheath. Terumo’s new precision access system eliminates the need for both a micropuncture kit and a standard size introducer sheath. It features proven TIF technology and a new tapered 21 gauge needle that allow for a smaller, straighter and more accurate puncture to significantly reduce vessel entry site trauma and access complications.

The system was designed and developed at Terumo’s manufacturing facility in Elkton, Md. The upgraded facility combines manufacturing and new product development teams in the same geographic location to streamline research and development while maximizing manufacturing efficiencies.

For more information:

Related Content

New Appropriate Use Criteria Released for Peripheral Artery Interventions
News | Peripheral Artery Disease (PAD) | December 19, 2018
A new set of appropriate use criteria (AUC) released Dec. 17 by a group of cardiovascular professional societies...
Lithotripsy Safe and Effective in Calcified Stenotic Peripheral Arteries
News | Peripheral Artery Disease (PAD) | December 04, 2018
New results from the DISRUPT PAD II study showed no perforations, embolization, reflow or abrupt closures with the...
Lutonix 014 Drug-Coated Balloon Safe and Effective Below the Knee
News | Peripheral Artery Disease (PAD) | November 07, 2018
The Lutonix Drug-Coated Balloon (DCB) showed statistically significant safety equivalence with a standard percutaneous...
Lokai Medical to Distribute NuCryo Vascular PolarCath Balloon Dilatation System in U.S.
News | Peripheral Artery Disease (PAD) | August 14, 2018
NuCryo Vascular announced that the company has signed a commercialization agreement with Lokai Medical, a specialty...
PQ Bypass Effective in Treating Extremely Long SFA Lesions at 12 Months
News | Peripheral Artery Disease (PAD) | July 02, 2018
The PQ Bypass Detour System showed promising 12-month durability for patients with extremely long blockages in the...
SCAI Releases Consensus Guidelines for Femoral-Popliteal Arterial Interventional Device Selection
News | Peripheral Artery Disease (PAD) | May 15, 2018
The Society for Cardiovascular Angiography and Interventions (SCAI) has released new guidelines to address the...
SCAI Launches Diagnosis and Treatment Toolkit for Peripheral Artery Disease
News | Peripheral Artery Disease (PAD) | May 14, 2018
The Society for Cardiovascular Angiography and Interventions (SCAI) announced the launch of the SCAI PAD Diagnosis and...
Critical Limb Ischemia Treatment Shows No Improvement at Three Months
News | Peripheral Artery Disease (PAD) | March 23, 2018
Patients with foot ulcers or gangrene who received the experimental drug JVS-100 did not show evidence of faster wound...
FDA Clears Corindus CorPath GRX for Peripheral Vascular Interventions
Technology | Peripheral Artery Disease (PAD) | February 20, 2018
Corindus Vascular Robotics Inc. announced today that it received 510(k) clearance from the U.S. Food and Drug...
Overlay Init